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Towards theoretically robust evidence on health equity: A systematic 
approach to contextualizing equity-relevant randomized controlled trials 
 
INTRODUCTION 
Reducing inequalities in health and the determinants of health is a widely acknowledged 
health policy goal [1, 2], and methods for measuring inequalities and inequities in health are 
well developed [3-5]. Yet, the evidence base is weak for how to achieve these goals. There is 
a lack of high-quality randomized controlled trials reporting impact on the distribution of 
health and non-health benefits, and lack of methodological rigour in how to design, power, 
measure, analyse, and interpret distributional impact in randomized controlled trials (RCTs) 
[6, 7]. 
One reason is that this is a new and growing field of research and standards are not yet well 
established. Another reason is that equality and equity are inherently complex notions [8], and 
lack of clarity about which underlying health equity framework, if any, is used as basis for 
choosing inequality measures may hamper agreement and standardisation. Recent work has 
begun to address these issues: Welch et al’s CONSORT-Equity extension proposes an 
approach for standardized and systematic reporting of health equity in randomized trials [9], 
and Jull et al have proposed a consensus-based approach to conceptualizing health-equity 
relevant RCTs [10]. However, there is more scope for discussing how equity relevance in 
RCTs can be linked more explicitly to broader theories of health equity. Different conceptions 
of health equity will have different implications for the kinds of studies that should be 
undertaken and for the analysis and interpretation of the results.  
Our overarching aim in this paper is to contribute to this emerging effort towards greater 
transparency and coherence in the theoretical and conceptual basis for RCTs on effective 
interventions to reduce health inequity. We endeavour to achieve this aim by pursuing two 
more specific objectives. First, we provide an overview of three major accounts of health 
equity in the literature, and clarify their implications for the measurement of health inequality 
in RCTs. Second, we seek to clarify the relationship between theory and translational 
challenges that researchers would need to attend to, in order to ensure that equity relevant 
RCTs are coherently grounded in theory.  
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We describe how to translate theory into practice in a consistent manner across the different 
stages of planning, conducting, and reporting the results of an equity-relevant RCT. We also 
outline some further concerns for researchers to address. 
 
WHAT IS HEALTH EQUITY? 
One key issue in debates about health equity in the philosophical and public health literature, 
is the question which inequalities in health are inequitable, or unjust.i There is a general 
consensus that not all inequalities are unjust, so we need an account of which inequalities are. 
Different theorists give different answers to that question. In the following, we propose an 
overview of three types of accounts of health equity. Our overview is not exhaustive, and 
some views may combine elements from the different categories. Furthermore, we do not here 
wish to argue in favour of one account over any of the others.ii 
Any account of health equity will, whether implicitly or explicitly, incorporate certain 
assumptions about the more fundamental question of how justice in health is related to 
distributive justice more broadly. Most plausibly, health is but one of several ‘currencies’ of 
justice within a pluralist framework, where justice concerns the distribution of more than one 
good (for example, health, income, and education). One underlying question, then, is the 
extent to which fairness in the distribution of health is contingent on the fairness of our social 
arrangements and the distribution of other justice-relevant goods. Following Peter [14], we 
can characterise accounts of health equity as ‘direct’ or ‘indirect’, depending on what position 
they take on this issue.  
On the direct approach, the distribution of health can in itself be just or unjust, independently 
of how other important social goods, such as income, are distributed. As Peter explains, the 
distribution of health is considered in isolation from other social spheres or goods, and health 
equity ‘is defined with respect to particular distributions of health outcomes’ [14]. One might 
take this view if one considers health to be ‘special’, or of greater moral importance than other 
constituents of overall well-being, such that we require a separate standard or principle of 
fairness for health. Anand [15], for example, argues that inequalities in health are generally 
                                                          
i We acknowledge that in drawing exclusively on the philosophical and public health literature on health 
inequality and inequity, we have left out other relevant and valuable perspectives, e.g. in the sociological 
literature on social class and inequality (Bourdieu [11, 12], Giddens [13]).  
ii In contrast, Welch et al [9] adopt a specific conception of health equity as the basis for their proposed 
CONSORT-Equity extension. 
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morally worse than inequalities in other goods, and that therefore we should be less accepting 
of inequality in the distribution of health. Needless to say, one can give different answers with 
respect to what level of inequality is acceptable. In addition, one might think that considering 
health inequalities through the lens of established theories of distributive justice might 
exclude potentially unfair health inequalities. Christopher Murray [16], who advocates taking 
a comprehensive approach to health inequality, represents this view: 
“Braveman et al believe that health inequalities correlated with factors other than income, 
social class, and race are not morally important. […] For a child with an increased risk of 
death because she lives in a community with a poor immunisation programme and a high 
prevalence of HIV, it is no solace to know that her risk of death is uncorrelated with income, 
social class, or race. To most of us, inequality is the state of being unequal. Health inequalities 
exist when individuals' risks of death and poor health are unequal.” 
On an indirect account of health equity, justice in health is interrelated with distributive 
justice more broadly. Whether or not a distribution of health is fair is contingent, in one way 
or another, on the distribution of other relevant goods. Here, we introduce a further distinction 
between two different (but not mutually exclusive) versions of this approach. The first 
version, most explicitly defended by Daniel Hausman [17, 18], conceives the correct ‘space’ 
of distributive justice as the distribution of overall well-being or advantage.iii We can call this 
the ‘overall disadvantage’ approach. The idea here is that the different components that make 
up well-being are to some extent substitutable, so that having more of one component can, 
partly or fully, make up for having less than another.iv This view of justice implies that, bar 
extremes, there is no particular distributive requirement for each of the relevant goods, or 
components of well-being, on its own. The particular distribution of one component of overall 
well-being, whether equal or unequal, is not ‘in itself’ unjust; rather, it is only unjust insofar 
as, and because, it reflects inequalities in well-being overall.  
The primary example of health inequalities that reflect inequalities in overall well-being are 
health inequalities between socio-economic groups – socio-economic class is one indicator of 
overall well-being, even more so when combined with health. These inequalities reflect 
systematic disadvantage across several components of well-being; those who have the worst 
                                                          
iii Here, we mean well-being in the very broadest sense, as in how ‘well off’ people are, and it might equally be 
understood as life prospects or resources or opportunities for well-being. 
iv Note some nuances with respect to different degrees of substitutability. At the margins, hardly any good is 
substitutable (see Hausman [17]). 
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health also have the lowest income and material security, the lowest level of education, the 
worst working conditions, and so on. Many of the social causes of ill health, such as poverty, 
are themselves forms of disadvantage, independently of their effects on health. 
Braveman’s view – although she does not make claims about the nature of justice as such – 
resembles Hausman’s view in that she is concerned with the broader picture, and with how 
being worse off with respect to health is related to the distribution of other goods [19-21]. She 
defines unjust inequalities in health as those ‘differences in health (or in important influences 
on health) that are systematically associated with being socially disadvantaged…, putting 
those in disadvantaged groups at further disadvantage’[20]. Deaton also emphasises that 
‘individual welfare is neither health nor wealth but depends upon both. The [social] gradient 
[in health] means that people who are deprived in terms of income and wealth are also 
deprived in terms of morbidity and mortality’[22]. Thus, on such a view, one would be 
concerned both with how health affects income and how income affects health [23]. 
The second version of the indirect approach focuses on the nature of the causes of health 
inequalities. We can call this the ‘unjust social causes’ approach. On this type of view, the 
fairness of health inequalities is taken to be derivative of the fairness of our social institutions: 
whether or not health inequalities are unjust depends on the social arrangements in which they 
come about. If our social institutions and their distributive principles are just, the resulting 
distribution of health will also be just. The most well developed and comprehensive defence 
of this view is Norman Daniels’ account [24]. Daniels adopts a (modified) Rawlsian 
framework of justice, and argues that the Rawlsian principles of justice provide an account of 
when the distribution of the social determinants of health is fair (see also Daniels et al [25]). 
On this account, justice in health turns out to be secondary to justice more broadly construed, 
because what counts as a just distribution of health depends on what counts as a just 
distribution of social resources more generally. 
It is possible to take a view that combines elements of both of these versions of the indirect 
approach. One example of such a view – or, at least, a view which does not fall clearly into 
either category – is that of Margaret Whitehead. On Whitehead’s well-known definition, 
health inequalities are inequitable when they are ‘unnecessary and avoidable, but in addition, 
are also considered unfair and unjust’[26]. Whitehead is concerned with ‘unjust social or 
environmental influences’[26], which suggests that health inequalities are unjust when they 
are the result of causes that are unjust. In this respect, Whitehead’s view resembles Daniels’. 
And like Daniels’ view, it presupposes an independent account of fairness that allows us to 
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establish when the relevant social and material circumstances are unjust. Which health 
inequalities are unjust will ultimately depend on that account’s prescriptions. But Whitehead 
also indicates that health inequalities that result from the clustering and reinforcing of 
disadvantage are particularly unjust, and in this respect her view resembles Hausman’s view, 
in reflecting a concern with systematic disadvantage and inequalities in ‘overall’ well-being.  
 
MEASURING HEALTH INEQUALITY 
One’s conception of health equity will have implications for what measures of health 
inequality are most likely to be relevant, which, in turn, will matter for how RCTs are 
designed, reported, and interpreted. Different health measures yield different kinds of 
information about health distributions, and different kinds of information may have different 
degrees of relevance depending on one’s underlying moral concern. 
One measurement issue that has been much debated in the health inequality literature is the 
use of univariate or bivariate measures of health inequality (see e.g. [4, 17, 19, 27-29]). In 
general, we can think of the bivariate measure as already linked to existing theories of justice 
(and the indirect framework of equity), whereas the univariate measure is more open-ended 
(and linked to the direct framework of health equity). 
The bivariate measure has usually been favoured by those who see justice in health as 
interrelated with social justice more generally (see e.g. Braveman et al [19] or Hausman [19]). 
Bivariate measurements measure health in combination with another group attribute, such as 
income, education, occupation, race, sex, or rural or urban residence. Thus, the bivariate 
measure reflects how health outcomes or expectancies vary with other factors that determine 
or are associated with overall well-being. A bivariate measure is also informative if one is 
particularly concerned with health inequalities that have social causes, or if one believes that 
inequalities due to chance are not unfair. Generally, a bivariate measure is more likely to 
direct us towards systematic causes. Firstly, the effects of chance may be factored out within a 
group because the bivariate measure gives us the average health of the members of the 
groups. Secondly, a systematic pattern of inequality between groups is unlikely to be caused 
by pure chance and suggests a non-arbitrary cause. Thus, Braveman et al argue in favour of 
the bivariate approach, on the grounds that ‘[e]quity does not refer to all health disparities—
for example, in the United States, the average birth weight of girls is lower than that of boys, 
but this disparity is unlikely to reflect inequity. Equity concerns a special subset of health 
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disparities that are particularly unfair because they are associated with underlying social 
characteristics, such as wealth, that systematically put some groups of people at a 
disadvantage with respect to opportunities to be healthy’ [19]. 
On the other hand, Christopher Murray argues that health inequalities should be measured 
comprehensively, rather than selectively, and thus favours the univariate approach. The 
univariate measure measures only a single variable, the health outcome or expectation of each 
individual, and as such gives us the ‘pure’ health distribution. Furthermore, the univariate 
measure reflects the total amount or range of health inequality in a given population – the unit 
of analysis always remains the individual, and therefore there is only one way in which the 
health inequality of that population can be represented (for a given health indicator) [27]. In 
contrast, the bivariate measure shows us health inequality as ‘filtered’ or organised in a 
certain way, typically social factors like income or social class. Thus, the bivariate measure, 
unlike the univariate measure, does not reflect the ‘total’ inequality in the population [27]. 
Furthermore, the bivariate measure often reflects health as a group average, and thus fails to 
capture within-group inequalities [27, 29, 30]. Murray is concerned that the bivariate 
approach excludes health inequalities that are not associated with income or class but may 
nevertheless be unfair, on his view, such as health inequalities caused by inequalities in 
‘environmental sanitation, water supply, health services, and social norms about risk factors’ 
[16].  
The univariate approach is interesting, and relevant for RCTs, because the social determinants 
usually explain only a fraction of the observed inequality. As described above, a direct 
approach to health equity includes a broader set of health inequality as potentially unfair, not 
just those reflecting inequality in overall well-being or are associated with socially organised 
determinants of health [31]. Those who agree with Murray, that all inequalities associated 
with factors beyond individual control, such as lack of a proper immunization programme or 
the result of the genetic lottery, may be unfair, may argue that these differences should also be 
measured in RCTs. The scope of our measures should be broad and include all inequalities in 
health between individuals (as well as non-health factors, if relevant). Then inequalities can 
be identified as fair or unfair at a later stage of the analysis [32, 33]. 
THE ROLE OF EQUITY FRAMEWORKS FOR EQUITY-RELEVANT RCTs 
So far we have presented an overview of three major health equity frameworks. How are 
these frameworks linked to conclusions about equity based on the experimental design of 
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RCTs? A recent paper defines an equity-relevant RCT as an RCT that assesses the effects of 
an intervention on health equity [9]. Its objectives might include increasing our understanding 
of, as well as gathering evidence about, how to reduce unfair inequalities or prevent such 
inequalities from arising. RCTs measure the effects of an intervention. The basic idea of 
equity-relevant trials is that: a) average differences in primary and secondary outcomes 
between the control and intervention arms can be attributed to the intervention; and b) that 
beyond average effects, it may also be possible and desirable to look at impact on 
distributions within each arm of the study. The design presumes a certain degree of variation 
in primary and secondary outcomes, and/or in characteristics of individuals or groups that 
allow for measuring a difference between the arms. Precisely which characteristics should be 
included depends on the chosen equity framework. If effects of an intervention are unequally 
distributed, the analysts can evaluate whether this change should be considered an equity 
improvement or not. 
With respect to RCTs, several additional, normative judgements are required to help translate 
a theoretical understanding of equity into the relevant context. Such judgements concern 
various practical and methodological issues, which we discuss in further detail below. The 
results of such considerations provide a complete narrative that helps to clarify which 
contextualized definition of equity has informed a particular RCT.v Furthermore, including an 
explicit justification of the choice of equity framework will enable others to critically assess 
the normative validity of the study.vi   
 
FROM GENERAL FRAMEWORKS OF HEALTH EQUITY TO 
CONTEXTUALIZED STUDIES OF DISTRIBUTIONAL IMPACT 
In order to apply a general framework or account of health equity to a specific setting, such as 
for the purposes of a particular RCT study, the framework must be contextualized, i.e. 
interpreted and specified in relation to the relevant setting. Researchers conducting RCTs  
need to base their approaches on what is practically feasible, but may nevertheless translate 
theoretical work on equity into this ‘real world setting’ [34]. This process of translation 
requires researchers to make additional normative judgements about how to apply a general 
                                                          
v A ‘contextualized definition’ here denotes an interpretation and application of the general framework to a 
concrete setting. We discuss this issue further in a later section in the paper. 
vi We acknowledge that standardized reporting formats may not allow the space for this, and suggest that this 
information could be included in an appendix. 
8 
 
concept of equity in a specific context. Examples of such judgements include the delimitation 
of what should be considered relevant concerns in a particular context, the identification of 
acceptable levels of inequality versus conclusions about baseline inequity, consistent choice 
of variables, reporting of findings, choice of measures of inequality, and how to assess 
whether a change in the distribution of relevant outcomes constitutes an improvement in 
equity or not. Such judgements are typically not adequately predicted or described within a 
theory or general definition itself; general theories or definitions usually do not encompass 
conditions for their application to a specific context or setting. In the following, we will 
consider, step-by-step, how a health equity framework can be translated into judgments about 
equitable impacts of health-related interventions (see Table 1 for a summary). We thereby aim 
to offer guidance for systematic reflection on different aspects of equity-relevance in RCT 
research throughout planning, conducting, and reporting.  
 
Translating measurements of equality into conclusions about equity 
In order to translate quantitative measurements of the distributional impact of intervention 
outcomes into normative conclusions about impact on equity, an overall normative 
justification is required – with respect to what kind of equality, and equality in relation to 
whom, we should consider fair. Independently of the kind of equity-relevant RCTs one is 
conducting, this overall normative argument can be broken down into different kinds of 
equity judgements that apply to different stages of the research process. We propose that the 
different stages of the planning and conducting of an equity-relevant RCT can be 
distinguished as follows: i) designing a study and choosing equity-relevant outcomes and 
stratifying factors; ii) data collection; iii) analysing and reporting distributions; iv) drawing 
conclusions regarding the impact on equity; and v) if appropriate, suggesting 
recommendations in accordance with the normative conclusions (e.g. implications for further 
research, or for how the findings can provide input to policy processes). In the interest of 
keeping it simple, we combine the two first and the two latter stages, respectively, and 
distinguish between: i) Designing equity-relevant RCTs and collecting equity-relevant data, 
ii) analysing and reporting health equity-relevant data, and iii) drawing conclusions 
regarding health equity and recommending further actions.vii  
                                                          
vii As discussed above, recommendations should be limited to implications for further research and outlining how 
the findings can provide input to policy processes. 
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Ideally, the justification of contextualized stage-dependent, equity-relevant considerations 
should cohere with a reasonable theoretical understanding of health equity. That is, the 
justification should be traceable and formulated in accordance with one of the theoretical 
accounts of health equity - or at least a consistent framework derived from such an account. 
All additional normative judgements called for in the translational process should be reported 
as part of the overall understanding of the particular equity definition of the RCT in question. 
In the following, we elaborate on the different stages of the research process. 
 
i) Designing equity-relevant RCTs and collecting equity-relevant data 
In the first stage of the research process, choices are made with respect to primary and 
secondary outcomes and stratifying factors that allow for equity assessments. Furthermore, it 
must be decided whether measuring impact of interventions across individuals or stratified 
groups (or both) is the best approach. 
If the study overall concerns effects on people who are already defined as disadvantaged, a 
normative argument is needed to explain why this part of the population is disadvantaged and 
how the perceived disadvantage is related to judgements about health equity. If, instead, the 
study aims to map differences in effect across groups within a population, a normative 
justification is required to account for which stratifying factors would be relevant for drawing 
conclusions regarding health equity. Welch et al [6] helpfully recommend considering the 
‘PROGRESS+’ categories as potentially relevant stratifying factors for equity assessments: 
place of residence, race/ethnicity, occupation, gender, religion, education, socioeconomic 
status, and social capital—plus age, sexual orientation, and disability [35]. 
While the former type of RCT makes specific judgements about who should be considered 
disadvantaged [6], the latter leaves that to some degree open (by identifying who is adversely 
affected).  
 
ii) Analysing and reporting health equity-relevant data 
In the stage for analysing and reporting on health equity-relevant data, new, specifying 
arguments are required for the complete, normative narrative of particular RCTs.  To ensure 
transparency, decisions made in this stage must be clarified and justification should be offered 
for the selection of data to be reported. Different perspectives or interpretations of data may 
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pull in different directions and should be addressed: How should the distribution of effects be 
presented (e.g. relative versus absolute), and why? If any potentially biasing stipulations have 
been made with respect to uncertainty in the data set, how are they justified and how does it 
affect the distribution of effects? How is the cut-off level that distinguishes between equality 
and inequality justified? All of these concerns come as additional specifications of 
fundamental theories about health equity, and researchers should aim to report accordingly.  
 
iii) Drawing conclusions regarding health equity and recommending further actions  
When drawing conclusions about equity with respect to the measured distribution in a given 
study, a normative argument justifying why the results represent a positive or negative impact 
on equity is required. How do the results reflect inequity, given the original, general definition 
structuring the design of the study (for example, with reference to Whitehead’s definition of 
health equity, how would ‘avoidable’ and ‘unnecessary’ be specified in a given setting)? If the 
aim is to gather evidence on how to reduce existing inequities, does the equity theory that 
structures the design of this RCT cohere with the theory that supports the categorisation of 
identified inequalities as ‘inequities’? 
In the case of RCTs, in describing a distribution as equity-relevant, one has conceptually 
acknowledged that the resulting - or already existing - inequality is unfair. Thus, it is implied 
that action ought to be taken to eliminate, reduce, or prevent the inequity. This should be 
spelled out in the report. However, it does not follow that all equity-relevant RCTs need end 
up with specific policy-recommendation; that could rather be the outcome of broader political 
decision-making processes.  
 
 
 
 
Table 1: Framework for contextualised equity definitions 
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Designing equity-
relevant RTCs and 
collecting equity-
relevant data 
 
 
Analysing and reporting 
health equity-relevant 
data 
 
Concluding on 
health equity and 
recommending 
further actions  
Are you studying 
the effects (in 
health- or non-
health benefit) in a 
population 
considered to be 
disadvantaged? 
Clarify and 
contextualize: 
-What do you mean 
by  
'health equity' in this 
particular  
context? 
 
-Who are the 
disadvantaged?  
-Why is their 
disadvantage a matter 
for equity 
considerations? 
 
Clarify and justify: 
-How is the selected, 
presented data chosen? 
 
What was the 
considerations with 
respect to:  
- what stratifying factors 
to present? 
-how to present the 
distribution of effects? 
-methods of measuring 
(in)equality and 
consequences for what is 
measured? 
 
-Why is (in)equality in 
the distribution of effects  
 (in)equitable? 
 
-Are there potentially  
equity relevant biases in  
the material? 
 
-Are there any alternative 
equity-relevant ways of 
reporting? 
 
-Are any potentially 
biasing stipulations 
made with respect to 
uncertainty in the data?  
 
-Where is the cut-off 
level that distinguishes 
between equality and 
inequality in effects put 
statistically, and why?  
 
- Are there any potential 
positive or negative side-
effects of the 
intervention? If yes, how 
Clarify and 
justify: 
-How does the 
presented data 
reflect health (in) 
equity? 
 
-Is there 
consistency in 
how equity has 
been accounted 
for throughout 
the research 
process? 
 
-What further 
actions are 
required by the 
findings of this 
study? 
 
- Are new studies 
(quantitative or 
qualitative) 
required? 
 
-How may the 
data and 
knowledge 
generated by the 
study be relevant 
for policies, and 
in what ways can 
it provide input to 
the policy 
process? 
 
 
Are you studying 
differences or 
equivalence in 
effects (in health- 
or non-health 
benefit) across 
stratifying factors? 
Clarify and 
contextualize: 
-What do you mean 
by 'health equity' in 
this particular 
context?  
 
-Why are the selected 
stratifying factors 
included? 
 
 
Are you studying a 
gradient of effects 
(in health- or non-
health benefit) 
across stratifying 
factors? 
Are you studying 
inequality (in 
health- or non-
health benefit) 
across individuals 
(independently of 
stratifying 
factors)? 
Clarify and 
contextualize: 
What do you mean by 
'health equity' in this 
particular study? 
  
-Why is the 
(in)equality in  
health outcome/access  
(in)equitable? 
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-Why are no selected 
stratifying factors 
included? 
may they influence 
(in)equality in health 
outcome or access? 
 
Table 1: Tentative framework of elements that go into a contextualised definition of equity in RCTs. Valid 
conclusions on (in)equity require transparency and report on all equity-relevant judgements being made 
throughout the process of designing, conducting and concluding on the equity relevance of a RCT. The list is not 
necessarily exhaustive, but can serve as a starting point for further mapping. 
 
Translating theory into practice: Overall concern 
Given the various normative assumptions and considerations that may underlie the 
conclusions drawn about health equity on the basis of an RCT, transparency is called for in all 
substantive judgments that shape the conclusion about equity impact. Justification of the 
normative assumptions and considerations can to some extent be provided with reference to a 
more general health equity framework. In addition, further specifications of normative 
assessments required for translation to take place should be accounted for. We have here 
outlined some concerns as a starting point. We believe the experiences of researchers 
conducting equity-relevant RCTs are called for to provide further detail and to expand on this 
overview, and will warmly welcome such contributions. 
 
CONCLUSION 
In this paper, we have considered how equity-relevant randomized controlled trials can be 
linked to philosophical theories of health equity. Our purpose was to explore how the 
evidence base on effective interventions to reduce health inequity can be strengthened by 
making it more conceptually coherent and transparent. Our approach has been twofold. First, 
we have provided an overview of three major health equity frameworks and their different 
implications for the measurement of health inequality. Second, we have described a flexible, 
step-wise approach to conducting equity-relevant trials that covers a wide range of equity-
relevant concerns throughout the various stages of the research process. We do not claim that 
our account is exhaustive, but rather intend for it to provide a starting point for further 
discussion as we gain more experience with equity-relevant RCTs. 
 
 
13 
 
REFERENCES 
[1] Marmot M. Fair Society Healthy Lives. In N. Eyal et al (eds) Inequalities in Health: 
Concepts, Measures and Ethics, Oxford: Oxford University Press; 2013. 
[2] Marmot M, Allen J, Goldblatt P et al. Fair Society, Healthy Lives: Strategic Review of 
Health Inequalities in England Post-2010, Ministry of Health UK: London; 2010. 
[3] O'Donnell O, van Doorslaer E, Wagstaff A et al. Analyzing Health Equity Using Household 
Survey Data: A Guide to Techniques and Their Implementation. Washington, DC: The World 
Bank; 2008. 
[4] Asada Y. Health Inequality: Morality and Measurement, Canada: University of Toronto 
Press; 2007. 
[5] Eyal N, Hurst S, Norheim OF et al. Inequalities and inequities in health. In N. Eyal et al 
(eds) Inequalities in Health: Concepts, Measures and Ethics, Oxford: Oxford University Press; 
2013. 
[6] Welch V, Petticrew M, Tugwell P et al. PRISMA-Equity 2012 Extension: Reporting 
Guidelines for Systematic Reviews with a Focus on Health Equity. PLoS Med 2012;9:1-7. 
[7] Welch V, Jull J, Petkovic R et al. Protocol for the development of a CONSORT-equity 
guideline to improve reporting of health equity in randomized trials. Implement Sci 
2015;10:146-157. 
[8] Temkin L. Inequality and Health.  In N. Eyal et al (eds) Inequalities in Health: Concepts, 
Measures and Ethics, Oxford: Oxford University Press; 2013. 
[9] Welch V, Norheim OF, Jull J et al. Better reporting of health equity in randomised trials: 
CONSORT-Equity extension and elaboration. BMJ forthcoming. 
[10] Jull J, Whitehead M, Petticrew M et al. When is a randomised controlled trial health equity 
relevant? BMJ Open 2017;7:e015815. doi: 10.1136/bmjopen-2016-015815. 
[11] Bourdieu P. Distinction: A Social Critique of the Judgement of Taste, Cambridge, MA: 
Harvard University Press; 1987.  
[12] Bourdieu P. Outline of a Theory of Practice, Cambridge: Cambridge University Press; 
1977. 
[13] Giddens A. The Class Structure of the Advanced Societies, London: Hutchinson; 1973. 
[14] Peter F. Health Equity and Social Justice. J Appl Philos 2001;18:159-170. 
[15] Anand S. The Concern for Equity in Health. J Epidemiol Community Health 2002;56:485-
487. 
[16] Murray CJL. Commentary: Comprehensive studies are needed for full understanding. BMJ 
2001;323:680-681. 
[17] Hausman DM. What’s Wrong with Health Inequalities? J Polit Philo 2007;15:46-66. 
[18] Hausman DM. Egalitarian Critiques of Health Inequalities. In N. Eyal et al (eds) 
Inequalities in Health: Concepts, Measures and Ethics, Oxford: Oxford University Press; 2013. 
14 
 
[19] Braveman P, Starfield B, Geiger HJ. World Health Report 2000: how it removes equity 
from the agenda for public health monitoring and policy. BMJ 2001;323:678-81. 
[20] Braveman P. Health Disparities and Health Equity: Concepts and Measurement. Annual 
Review of Public Health 2006;27:167-194. 
[21] Braveman P, Kumanyika S, Fielding J et al. Health disparities and health equity: The 
issue is justice. Am J Public Health 2011;101:S149-S155. 
[22] Deaton A. Policy Implications of the Gradient of Health and Wealth. Health Affairs 
2002;21:13-30. 
[23] Deaton A. What Does the Empirical Evidence Tell Us About the Injustice of Health 
Inequalities? In N. Eyal et al (eds) Inequalities in Health: Concepts, Measures and Ethics, 
Oxford: Oxford University Press; 2013. 
[24] Daniels N. Just health: Meeting health needs fairly, Cambridge: Cambridge University 
Press; 2008. 
[25] Daniels N, Kennedy B, Kawachi I. Why Justice is Good for Our Health: Social 
Determinants of Health Inequalities. Daedalus 1999;128: 215-251. 
[26] Whitehead M. The Concepts and Principles of Equity and Health. Health Promot Int 
1991;3:217-228. 
[27] Asada Y. A Summary Measure of Health Inequalities: Incorporating Group and 
Individual Inequalities. In N. Eyal et al (eds) Inequalities in Health: Concepts, Measures and 
Ethics, Oxford: Oxford University Press; 2013. 
[28] Hausman DM, Asada Y, Hedemann T. Health Inequalities and Why They Matter. Health 
Care Anal 2002;10:177-191. 
[29] Murray CJL, Gakidou EE, Frenk J. Health Inequalities and Social Group Differences: 
What Should We Measure? Bull World Health Organ 1999;77:537-543. 
[30] Lippert-Rasmussen K. When group measures of health should matter. In N. Eyal et al 
(eds) Inequalities in Health: Concepts, Measures and Ethics, Oxford: Oxford University 
Press; 2013. 
[31] Wagstaff A and van Doorslaer E. Overall versus socioeconomic health inequality: a 
measurement framework and two empirical illustrations. Health Econ 2004;13: 297-301. 
[32] Asada Y, Hurley J, Norheim OF et al. A three-stage approach to measuring health 
inequalities and inequities. Int J Equity Health 2014;13:98-111. 
[33] Asada Y, Hurley J, Norheim OF et al. Unexplained health inequality--is it unfair? Int J 
Equity Health 2015;14:11-23. 
[34] Bærøe K. Translational ethics: an analytical framework of translational movements 
between theory and practice and a sketch of a comprehensive approach. BMC Med Ethics 
2014;15:71-78. 
15 
 
[35] Tugwell P, Petticrew M, Kristjansson E et al. Assessing equity in systematic reviews: 
realising the recommendations of the Commission on Social Determinants of Health. 
BMJ 2010;341:c4739. 
 
 
